288 related articles for article (PubMed ID: 26647716)
41. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration.
Shi J; Zhang X; Jiang L; Zhang L; Dong Y; Midgley AC; Kong D; Wang S
Acta Biomater; 2019 Oct; 97():360-373. PubMed ID: 31351251
[TBL] [Abstract][Full Text] [Related]
42. Resolvin D3 multi-level proresolving actions are host protective during infection.
Norris PC; Arnardottir H; Sanger JM; Fichtner D; Keyes GS; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2018 Nov; 138():81-89. PubMed ID: 26858146
[TBL] [Abstract][Full Text] [Related]
43. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.
Mueller-Ortiz SL; Drouin SM; Wetsel RA
Infect Immun; 2004 May; 72(5):2899-906. PubMed ID: 15102802
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic effects of high molecular weight hyaluronic acid in severe
Zhang X; Sugita S; Liu A; Naito Y; Hwang W; Qiu H; Sakamoto A; Sawa T; Matthay MA; Lee JW
Am J Physiol Lung Cell Mol Physiol; 2021 Nov; 321(5):L827-L836. PubMed ID: 34524905
[TBL] [Abstract][Full Text] [Related]
45. Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.
Haydar D; Gonzalez R; Garvy BA; Garneau-Tsodikova S; Thamban Chandrika N; Bocklage TJ; Feola DJ
Immunobiology; 2021 Jan; 226(1):152034. PubMed ID: 33278710
[TBL] [Abstract][Full Text] [Related]
46. Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation.
Ojielo CI; Cooke K; Mancuso P; Standiford TJ; Olkiewicz KM; Clouthier S; Corrion L; Ballinger MN; Toews GB; Paine R; Moore BB
J Immunol; 2003 Oct; 171(8):4416-24. PubMed ID: 14530368
[TBL] [Abstract][Full Text] [Related]
47. GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections.
Flak MB; Koenis DS; Sobrino A; Smith J; Pistorius K; Palmas F; Dalli J
J Clin Invest; 2020 Jan; 130(1):359-373. PubMed ID: 31793912
[TBL] [Abstract][Full Text] [Related]
48. CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice.
Wang Q; Teder P; Judd NP; Noble PW; Doerschuk CM
Am J Pathol; 2002 Dec; 161(6):2219-28. PubMed ID: 12466136
[TBL] [Abstract][Full Text] [Related]
49. Extrathoracic multiple trauma dysregulates neutrophil function and exacerbates pneumonia-induced lung injury.
Leonard JM; Zhang CX; Lu L; Hoofnagle MH; Fuchs A; Clemens RA; Ghosh S; Hughes SW; Bochicchio GV; Hotchkiss R; Turnbull IR
J Trauma Acute Care Surg; 2021 Jun; 90(6):924-934. PubMed ID: 34016916
[TBL] [Abstract][Full Text] [Related]
50. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.
Steinhauser ML; Hogaboam CM; Kunkel SL; Lukacs NW; Strieter RM; Standiford TJ
J Immunol; 1999 Jan; 162(1):392-9. PubMed ID: 9886412
[TBL] [Abstract][Full Text] [Related]
51. The Protectin PCTR1 Is Produced by Human M2 Macrophages and Enhances Resolution of Infectious Inflammation.
Ramon S; Dalli J; Sanger JM; Winkler JW; Aursnes M; Tungen JE; Hansen TV; Serhan CN
Am J Pathol; 2016 Apr; 186(4):962-73. PubMed ID: 26878209
[TBL] [Abstract][Full Text] [Related]
52. Lipocalin 2 is protective against E. coli pneumonia.
Wu H; Santoni-Rugiu E; Ralfkiaer E; Porse BT; Moser C; Høiby N; Borregaard N; Cowland JB
Respir Res; 2010 Jul; 11(1):96. PubMed ID: 20633248
[TBL] [Abstract][Full Text] [Related]
53. Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia.
Cohen TS; Prince AS
J Clin Invest; 2013 Apr; 123(4):1630-7. PubMed ID: 23478406
[TBL] [Abstract][Full Text] [Related]
54. Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage.
Rymut N; Heinz J; Sadhu S; Hosseini Z; Riley CO; Marinello M; Maloney J; MacNamara KC; Spite M; Fredman G
FASEB J; 2020 Jan; 34(1):597-609. PubMed ID: 31914705
[TBL] [Abstract][Full Text] [Related]
55. Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.
Marion CR; Wang J; Sharma L; Losier A; Lui W; Andrews N; Elias JA; Kazmierczak BI; Roy CR; Dela Cruz CS
Infect Immun; 2016 Jul; 84(7):2094-2104. PubMed ID: 27141083
[TBL] [Abstract][Full Text] [Related]
56. FcgammaRIII is protective against Pseudomonas aeruginosa pneumonia.
Rhein LM; Perkins M; Gerard NP; Gerard C
Am J Respir Cell Mol Biol; 2008 Apr; 38(4):401-6. PubMed ID: 17975174
[TBL] [Abstract][Full Text] [Related]
57. Keratinocyte growth factor supports pulmonary innate immune defense through maintenance of alveolar antimicrobial protein levels and macrophage function.
Gardner JC; Wu H; Noel JG; Ramser BJ; Pitstick L; Saito A; Nikolaidis NM; McCormack FX
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(9):L868-79. PubMed ID: 26919897
[TBL] [Abstract][Full Text] [Related]
58. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia.
Song Z; Kharazmi A; Wu H; Faber V; Moser C; Krogh HK; Rygaard J; Hoiby N
Clin Diagn Lab Immunol; 1998 Nov; 5(6):882-7. PubMed ID: 9801351
[TBL] [Abstract][Full Text] [Related]
59. Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-α expression.
Lee HN; Kundu JK; Cha YN; Surh YJ
J Cell Sci; 2013 Sep; 126(Pt 17):4037-47. PubMed ID: 23788426
[TBL] [Abstract][Full Text] [Related]
60. AT-RvD1 Mitigates Secondhand Smoke-Exacerbated Pulmonary Inflammation and Restores Secondhand Smoke-Suppressed Antibacterial Immunity.
Bhat TA; Kalathil SG; Bogner PN; Lehmann PV; Thatcher TH; Sime PJ; Thanavala Y
J Immunol; 2021 Mar; 206(6):1348-1360. PubMed ID: 33558371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
